MeiraGTx Holdings Plc (NASDAQ:MGTX): Are Analysts Optimistic?
BofA Securities Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Maintains Target Price $14
Buy Rating for Meiragtx Holdings: Promising Secondary Endpoint Results and Regulatory Optimism Drive Confidence
Top Premarket Decliners
Investors Await Jobless Claims, Housing, Manufacturing Data as US Futures Trend Lower Thursday Premarket
Some MeiraGTx Holdings Plc (NASDAQ:MGTX) Shareholders Look For Exit As Shares Take 33% Pounding
MeiraGTx Holdings Signs New Lease in New York
Is MeiraGTx Holdings (NASDAQ:MGTX) Using Debt In A Risky Way?
MeiraGTx Holdings Plc (NASDAQ:MGTX) Is Expected To Breakeven In The Near Future
MeiraGTx Holdings (MGTX) Partners With Hologen for $200M AI-Powered Parkinson's Treatment
MeiraGTx Holdings Is Maintained at Outperform by RBC Capital
MeiraGTx Hldgs Analyst Ratings
RBC Raises Price Target on MeiraGTx Holdings to $13 From $11, Keeps Outperform, Speculative Risk
BofA Securities Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Raises Target Price to $14
Bank of America Securities Sticks to Their Buy Rating for Meiragtx Holdings (MGTX)
MeiraGTx Holdings Faces Financial Uncertainty Over Priority Review Vouchers for Gene Therapy
Sector Update: Health Care Stocks Slipping Late Afternoon
MeiraGTx Shares Soar After Joint Venture Deal With Hologen
Top Midday Gainers
Crude Oil Falls 1%; Dollar General Posts Upbeat Sales